India Juris advises on acquisition of Saitech Medicare

31 January 2010

Protech Biosystems “Protech” is India’s highly progressive health management company involved in research, manufacturing and marketing of branded and generic pharmaceutical formulations. Protech Biosystems exports to Russia & CIS countries, South East Asia, African countries, Latin American countries.

India Juris assisted the Protech in acquisition of majority stakes in Chandigarh, India based pharma company Saitech Medicare Pvt Ltd. The complex transaction involved due diligence, corporate law advise, advise on capital gain tax, shareholders agreements and various other side letters, transfer of registrations and approvals etc.

The transaction was successfully completed to the satisfaction of the client.

News & Deals

India Juris Advises on NowPurchase INR 80 Cr Funding

India Juris in Kidbea’s INR 30 Crore Series A Funding Round

India Juris Advises on Hoopr’s Pre-Series A Funding Round

Publications

Global Regional Corporate Treasury Centre in IFSC, GIFT City

Obtaining a Payment Services Provider (PSP) Licence in GIFT IFSC: Regulatory Framework under IFSCA

Bridging Jurisdictions: Cross-Border Insolvency in The Gift City Paradigm

Newsletters

Amendments to the Insolvency and Bankruptcy Code, 2016 (2026 Amendment Bill)

SEBI on Open Market Buybacks – Analysis

The New 2026 IFSCA FinTech Sandbox Framework